1. Document de presse | 2024.11.21

    Phages, towards a targeted alternative to antibiotics

    With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists – although it remains complex in...

  2. Article | 2023.04.04

    4-year Research Group - Call for nomination at the Pasteur Fiocruz Center

    A 4-year Group leaders’ position is open at the Pasteur Fiocruz Center on Immunology and Immunotherapy

  3. News | 2025.12.10

    Ten Years of Pasteur MOOCs: Sharing Science Differently

    Since 2015, the digital education of the Institut Pasteur has been spreading science worldwide. Here’s a look back at a collective adventure that has already trained over 250,000 learners and transformed the way we share knowledge about infectious diseases.  

  4. Article | 2019.06.18

    Bacteria

    34 teams from seven departments are addressing the antibiotic resistance challenge with multidisciplinary approaches to characterize and prevent the emergence and the dissemination of antibiotic resistance genes and resistant bacteria and to develop new drugs and alternative strategies to fight bacterial infections.

  5. Document de presse | 2015.10.28

    The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center

    Paris, France and Los Angeles, CaliforniaThe Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the Institut Pasteur today announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality...

  6. News | 2023.03.22

    The origins of SARS-CoV-2: the search goes on

    Where did SARS-CoV-2 come from? How did this virus enter the human population? These questions still remain unanswered. In June 2022, a group of experts, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) commissioned by the World Health Organization (WHO), published a report on the origin of coronavirus but was unable to draw a definitive conclusion. Since then, research has...

  7. Document de presse | 2023.03.29

    World Autism Awareness Day: Institut Pasteur working actively with clinicians and the autism community

    As we mark World Autism Awareness Day on Sunday April 2, 2023, this year the Institut Pasteur is celebrating the 20th anniversary of the discovery of the first genes associated with autism. In 2003, this discovery offered a new perspective on the neurodevelopmental disorder; today, it highlights what still needs to be done to help those affected by autism. Scientists in international consortia...

  8. Document de presse | 2025.05.29

    Revelations on the History of Leprosy in the Americas

    Leprosy existed in America long before the arrival of Europeans: a new study reveals the history of a neglected pathogen.Long considered a disease brought to the Americas by European colonizers, leprosy may actually have a much older history on the American continent. Scientists from the Institut Pasteur, the CNRS, and the University of Colorado (USA), in collaboration with various institutions...

  9. Article | 2017.09.12

    Pasteur-Paris University enrollment 2018

    The 2017-2018 call for enrollment of students in October 2018 is open.

  10. Fiche maladie | 2022.06.03

    Autism

    Autism is a neurodevelopmental disorder (NDD). It appears in early childhood (before the age of 36 months) and affects children's developmental areas in different ways and to different degrees. In most cases, its effects impact on autistic individuals' level of independence and social interaction and participation. It is therefore important to diagnose the condition and take action as early as...

Pages

Back to top